No Patient Left Behind: Expanding Semaglutide’s Reach

Recent studies from Endocrine Society journals have shown that GLP-1 RAs are not only successful in reducing obesity, but they have positive impacts on a range of other conditions. From improving taste sensitivity and positive results in a pediatric patient with several comorbidities to being an effective treatment in patients with a variety of psychiatric […]

To view the full Member Resource, please Log in


TOPICS IN THIS ARTICLE:

Share this article